Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-06

Clinical Trial Update: Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding tamoxifen after combination chemotherapy benefits women with operable invasive breast cancer. The study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen (tamoxifen)

Snippet

Sponsor: Scottish Cancer Therapy Network | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED